Furthermore, another multi-target approach using a hybrid compound (GLP-1/xenin) has also been shown to improve glycemic control and reduce circulating lipid in a mouse model of obesity-induced type 2 diabetes [58]. Here, COPA is linked to obesity due to melanocortin 4 receptor deficiency.